Sofya N. Pchelina

Moscow, MOW, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 84 publications

Lipid-Laden M1-like Macrophages of Familial Hypercholesterolemia Patients Are Characterized by Increased Interleukin-1β Secretion and Reduced TMEM176A and TMEM176B Gene Expression.

Lipid-Laden M1-like Macrophages of Familial Hypercholesterolemia Patients Are Characterized by Increased Interleukin-1β Secretion and Reduced TMEM176A and TMEM176B Gene Expression.

Journal: Current issues in molecular biology

Published: June 25, 2026

Glucocerebrosidase dysfunction in GBA1 carriers: insights from blood and macrophage analyses.

Glucocerebrosidase dysfunction in GBA1 carriers: insights from blood and macrophage analyses.

Journal: Molecular biology reports

Published: May 21, 2026

mTOR Inhibition Drives Mutation-Specific Remodeling of Lysosomal and Autophagic Pathways and GCase Activity in PBMC-Derived Macrophages from Patients with GBA1-Associated Parkinson's Disease.

mTOR Inhibition Drives Mutation-Specific Remodeling of Lysosomal and Autophagic Pathways and GCase Activity in PBMC-Derived Macrophages from Patients with GBA1-Associated Parkinson's Disease.

Journal: Current issues in molecular biology

Published: April 08, 2026

The GBA1 p.E427K (p.E388K) Variant is a Risk Factor for Synucleinopathies: A Meta-Analysis.

The GBA1 p.E427K (p.E388K) Variant is a Risk Factor for Synucleinopathies: A Meta-Analysis.

Journal: medRxiv : the preprint server for health sciences

Published: March 27, 2026

The GBA1 p.E427K (p.E388K) Variant Is a Risk Factor for Synucleinopathies: A Meta-Analysis.

The GBA1 p.E427K (p.E388K) Variant Is a Risk Factor for Synucleinopathies: A Meta-Analysis.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: March 18, 2026

Simultaneous inhibition of mTOR and STING as an approach to reduce alpha-synuclein and lysosphingolipid levels in peripheral blood monocytederived macrophages and the SH-SY5Y cell line: implications for therapy of Parkinson's disease.

Simultaneous inhibition of mTOR and STING as an approach to reduce alpha-synuclein and lysosphingolipid levels in peripheral blood monocytederived macrophages and the SH-SY5Y cell line: implications for therapy of Parkinson's disease.

Journal: Biomeditsinskaia khimiia

Published: March 17, 2026

Rare-Variant Burden across Lysosomal Genes Implicates Sialylation and Ganglioside Metabolism in Parkinson's Disease.

Rare-Variant Burden across Lysosomal Genes Implicates Sialylation and Ganglioside Metabolism in Parkinson's Disease.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: March 10, 2026

Rare-variant burden across lysosomal genes implicates sialylation and ganglioside metabolism in Parkinson's disease.

Rare-variant burden across lysosomal genes implicates sialylation and ganglioside metabolism in Parkinson's disease.

Journal: medRxiv : the preprint server for health sciences

Published: February 27, 2026

Rare variants in cholesterol transporter genes in patients with lipid metabolism disorders.

Rare variants in cholesterol transporter genes in patients with lipid metabolism disorders.

Journal: Vavilovskii zhurnal genetiki i selektsii

Published: October 16, 2025

Correction: Transcriptomic analysis of differential expression between surviving and nonsurviving patients infected by the SARS-CoV-2 Delta variant.

Correction: Transcriptomic analysis of differential expression between surviving and nonsurviving patients infected by the SARS-CoV-2 Delta variant.

Journal: Scientific reports

Published: October 14, 2025

The Double Toxic MPTP+CBE Presymptomatic Parkinson-Like Phenotype in Mice.

The Double Toxic MPTP+CBE Presymptomatic Parkinson-Like Phenotype in Mice.

Journal: Biochemistry. Biokhimiia

Published: August 31, 2025

p.N370S GBA1 Mutation Influences the Morphology and Lipid Composition of Extracellular Vesicles in Blood Plasma from Patients with Parkinson's Disease.

p.N370S GBA1 Mutation Influences the Morphology and Lipid Composition of Extracellular Vesicles in Blood Plasma from Patients with Parkinson's Disease.

Journal: International journal of molecular sciences

Published: August 21, 2025

Showing 1-12 of 84

Last Updated: 09/26/2026